This study involved 309 HCC patients and investigated the clinical implications of RSAD2 gene upregulation in peripheral blood, in terms of its associations with survival, the presence of metastasis, and other clinical manifestations. The gene discussed is RSAD2; the disease is hepatocellular carcinoma.